The Next Step of Their Control Is Here …

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

BHVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 16.00%

Insider Buying (Last 12 Months): $14,301,316.23

Insider Selling (Last 12 Months): $459,690.00

Biohaven Insider Trading History Chart

Biohaven Share Price & Price History

^$38.99

▲ +0.45 (1.17%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Biohaven Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/24/2024	Gregory H. Bailey	Director	Buy	25,503	$39.18	$999,207.54	1,600,071
4/22/2024	Gregory H. Bailey	Director	Buy	48,780	$41.00	$1,999,980.00	1,574,568
4/22/2024	Vlad Coric	CEO	Buy	121,951	$41.00	$4,999,991.00	1,788,417
12/29/2023	Irina Antonijevic	Director	Sell	11,000	$41.79	$459,690.00	2,535
10/5/2023	Matthew Buten	CFO	Buy	22,727	$22.00	$499,994.00	189,380
10/5/2023	Vlad Coric	CEO	Buy	113,637	$22.00	$2,500,014.00	1,657,031
10/4/2023	Gregory H. Bailey	Director	Buy	17,817	$22.57	$402,129.69	1,525,788
8/30/2023	John W. Childs	Director	Buy	50,000	$18.44	$922,000.00	1,975,118
8/4/2023	John W. Childs	Director	Buy	100,000	$19.78	$1,978,000.00	1,925,118
10/31/2022	Vlad Coric	CEO	Buy	25,800	$15.97	$412,026.00	1,543,394
10/28/2022	Vlad Coric	CEO	Buy	41,930	$14.87	$623,499.10	1,517,594
10/25/2022	Gregory H. Bailey	Director	Buy	200,000	$10.50	$2,100,000.00	1,507,971
10/25/2022	Matthew Buten	CFO	Buy	142,857	$10.50	$1,499,998.50	166,653
10/25/2022	Vlad Coric	CEO	Buy	853,380	$10.50	$8,960,490.00	1,475,664
8/19/2022	Gregory H. Bailey	Director	Buy	38,000	$148.04	$5,625,520.00	2,583,658
5/10/2022	George C. Clark	CAO	Sell	4,200	$141.50	$594,300.00	4,065
1/19/2022	George C. Clark	CAO	Sell	9,375	$117.01	$1,096,968.75
12/20/2021	George C. Clark	CAO	Sell	1,915	$123.84	$237,153.60
12/20/2021	Julia P. Gregory	Director	Sell	12,000	$125.00	$1,500,000.00
12/15/2021	Elyse Stock	Insider	Sell	21,919	$105.49	$2,312,235.31
12/10/2021	James Engelhart	CFO	Sell	35,000	$102.55	$3,589,250.00
11/29/2021	Declan Doogan	Director	Sell	24,525	$112.80	$2,766,420.00
11/16/2021	Declan Doogan	Director	Sell	37,740	$116.65	$4,402,371.00
11/10/2021	John W. Childs	Director	Buy	5,000	$122.87	$614,350.00

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

88.78% of Biohaven stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biohaven Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2024	Cypress Wealth Services LLC	5,965	$0.33M	0.1%	N/A	0.007%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	253,000	$10.83M	0.0%	N/A	0.310%
3/1/2024	Goldman Sachs Group Inc.	945,715	$40.48M	0.0%	+8.2%	1.179%
2/26/2024	Perceptive Advisors LLC	1,725,047	$73.83M	1.7%	+129.4%	2.151%
2/20/2024	Eventide Asset Management LLC	401,101	$17.17M	0.3%	N/A	0.500%
2/16/2024	Price T Rowe Associates Inc. MD	3,134,323	$134.15M	0.0%	+33.8%	3.908%
2/15/2024	Opaleye Management Inc.	200,000	$8.56M	2.3%	-54.4%	0.249%
2/14/2024	First Light Asset Management LLC	383,757	$16.43M	1.3%	N/A	0.479%
2/14/2024	Point72 Asset Management L.P.	2,483,567	$106.30M	0.3%	+142.2%	3.097%
2/14/2024	Avidity Partners Management LP	1,148,308	$49.15M	1.8%	-10.7%	1.432%
2/14/2024	Bellevue Group AG	1,075,000	$46.01M	0.7%	N/A	1.340%
2/14/2024	Lighthouse Investment Partners LLC	30,964	$1.33M	0.1%	N/A	0.039%
2/14/2024	Harvest Management LLC	15,100	$0.65M	0.6%	-3.2%	0.019%
2/14/2024	Seven Eight Capital LP	13,110	$0.56M	0.1%	N/A	0.016%
2/13/2024	Armistice Capital LLC	1,500,000	$64.20M	0.9%	-26.3%	1.870%
2/13/2024	Affinity Asset Advisors LLC	20,866	$0.89M	0.2%	-30.8%	0.026%
2/13/2024	Rafferty Asset Management LLC	271,577	$11.62M	0.0%	-20.8%	0.339%
2/13/2024	Prevail Innovative Wealth Advisors LLC	5,385	$0.23M	0.1%	N/A	0.007%
2/12/2024	Capstone Investment Advisors LLC	5,486	$0.24M	0.0%	N/A	0.007%
2/12/2024	Stifel Financial Corp	6,225,811	$266.47M	0.3%	+7.9%	7.763%
2/12/2024	TD Asset Management Inc	276,172	$11.82M	0.0%	+31.0%	0.344%
2/8/2024	Nicholas Investment Partners LP	119,512	$5.12M	0.6%	-79.8%	0.149%
2/8/2024	First Turn Management LLC	477,314	$20.43M	2.9%	N/A	0.595%
2/7/2024	Principal Financial Group Inc.	27,935	$1.20M	0.0%	+47.6%	0.035%
2/7/2024	Teacher Retirement System of Texas	15,674	$0.67M	0.0%	-4.9%	0.020%
2/7/2024	E Fund Management Co. Ltd.	14,528	$0.62M	0.0%	-17.5%	0.018%
2/6/2024	Charles Schwab Investment Management Inc.	518,904	$22.21M	0.0%	+20.1%	0.647%
2/6/2024	Private Advisor Group LLC	5,388	$0.23M	0.0%	N/A	0.007%
2/6/2024	Swiss National Bank	134,100	$5.74M	0.0%	+5.2%	0.167%
2/5/2024	Victory Capital Management Inc.	158,513	$6.78M	0.0%	N/A	0.198%
2/5/2024	Thompson Davis & CO. Inc.	5,000	$0.21M	0.2%	N/A	0.006%
2/1/2024	New York State Common Retirement Fund	41,276	$1.77M	0.0%	+27.9%	0.051%
2/1/2024	Jennison Associates LLC	266,391	$11.40M	0.0%	N/A	0.332%
2/1/2024	Sigma Planning Corp	6,418	$0.28M	0.0%	-50.1%	0.008%
2/1/2024	Handelsbanken Fonder AB	12,500	$0.54M	0.0%	N/A	0.016%
1/31/2024	Federated Hermes Inc.	9,898	$0.42M	0.0%	N/A	0.012%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	15,863	$0.68M	0.0%	+45.2%	0.020%
1/30/2024	Canton Hathaway LLC	21,350	$0.91M	0.3%	-2.3%	0.027%
1/30/2024	Bison Wealth LLC	328,148	$14.05M	2.5%	-9.2%	0.409%
1/30/2024	Strs Ohio	9,100	$0.39M	0.0%	-62.2%	0.011%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	40,094	$1.72M	0.0%	+5.3%	0.050%
1/24/2024	Arizona State Retirement System	19,028	$0.81M	0.0%	+15.2%	0.024%
1/18/2024	Weybosset Research & Management LLC	13,640	$0.58M	0.2%	+12.4%	0.017%
1/16/2024	Simon Quick Advisors LLC	74,968	$3.21M	0.3%	+36.3%	0.093%
1/16/2024	Oak Ridge Investments LLC	7,802	$0.33M	0.0%	-7.5%	0.010%
1/16/2024	Raymond James Financial Services Advisors Inc.	8,473	$0.36M	0.0%	N/A	0.011%
1/16/2024	Raymond James & Associates	28,499	$1.22M	0.0%	+3.5%	0.036%
1/16/2024	Legato Capital Management LLC	10,960	$0.47M	0.1%	N/A	0.014%
1/12/2024	Constitution Capital LLC	7,000	$0.30M	0.2%	N/A	0.009%
1/8/2024	Harbor Capital Advisors Inc.	29,552	$1.27M	0.2%	+23.1%	0.037%
12/19/2023	Public Employees Retirement System of Ohio	9,060	$0.24M	0.0%	N/A	0.011%
12/18/2023	Vanguard Group Inc.	1,428,983	$37.17M	0.0%	-6.0%	1.781%
12/7/2023	Hudson Bay Capital Management LP	10,000	$0.26M	0.0%	-92.3%	0.012%
12/6/2023	Citigroup Inc.	146,907	$3.82M	0.0%	+97.9%	0.183%
11/30/2023	American Century Companies Inc.	510,235	$13.27M	0.0%	+13.5%	0.636%
11/15/2023	GSA Capital Partners LLP	35,490	$0.92M	0.1%	N/A	0.052%
11/15/2023	Redmile Group LLC	518,924	$13.50M	0.6%	N/A	0.760%
11/15/2023	Kennedy Capital Management LLC	55,000	$1.43M	0.0%	N/A	0.081%
11/15/2023	Adage Capital Partners GP L.L.C.	1,242,075	$32.31M	0.1%	-16.1%	1.818%
11/15/2023	Armistice Capital LLC	2,036,000	$52.96M	0.8%	+13.1%	2.980%
11/15/2023	Affinity Asset Advisors LLC	30,156	$0.78M	0.2%	N/A	0.044%
11/14/2023	Fred Alger Management LLC	70,721	$1.84M	0.0%	-38.9%	0.104%
11/14/2023	Avidity Partners Management LP	1,285,400	$33.43M	1.3%	-3.0%	1.881%
11/14/2023	Trexquant Investment LP	23,408	$0.61M	0.0%	-35.4%	0.034%
11/14/2023	Monashee Investment Management LLC	90,000	$2.34M	1.0%	+80.0%	0.132%
11/14/2023	O Shaughnessy Asset Management LLC	9,326	$0.24M	0.0%	-10.4%	0.014%
11/14/2023	Profund Advisors LLC	57,514	$1.50M	0.1%	+65.2%	0.084%
11/13/2023	EAM Investors LLC	87,552	$2.28M	0.4%	-20.3%	0.128%
11/13/2023	Stifel Financial Corp	5,769,749	$150.07M	0.2%	+2.7%	8.445%
11/13/2023	Clearbridge Investments LLC	431,973	$11.24M	0.0%	-0.3%	0.632%
11/13/2023	Dark Forest Capital Management LP	24,836	$0.65M	0.0%	+66.1%	0.036%
11/13/2023	Silverarc Capital Management LLC	10,000	$0.26M	0.1%	-50.0%	0.015%
11/13/2023	FMR LLC	3,259,133	$84.77M	0.0%	-16.6%	4.770%
11/13/2023	Rafferty Asset Management LLC	342,861	$8.92M	0.1%	+80.8%	0.502%
11/13/2023	Maven Securities LTD	225,000	$5.85M	0.1%	+12.5%	0.329%
11/13/2023	E Fund Management Co. Ltd.	17,608	$0.46M	0.0%	+72.7%	0.026%
11/9/2023	Deutsche Bank AG	41,737	$1.09M	0.0%	+8.5%	0.061%
11/9/2023	Citigroup Inc.	146,907	$3.82M	0.0%	+97.9%	0.215%
11/9/2023	UBS Group AG	88,588	$2.30M	0.0%	+2,642.7%	0.130%
11/8/2023	NJ State Employees Deferred Compensation Plan	10,250	$0.27M	0.0%	N/A	0.015%
11/8/2023	Charles Schwab Investment Management Inc.	432,014	$11.24M	0.0%	-14.0%	0.632%
11/8/2023	Swiss National Bank	127,500	$3.32M	0.0%	+1.0%	0.187%
11/7/2023	Virtus ETF Advisers LLC	4,057	$0.11M	0.1%	-9.0%	0.006%
11/7/2023	New York State Common Retirement Fund	32,276	$0.84M	0.0%	+29.9%	0.047%
11/7/2023	VELA Investment Management LLC	9,269	$0.24M	0.1%	-6.1%	0.014%
11/7/2023	Barclays PLC	175,913	$4.58M	0.0%	+57.1%	0.257%
11/6/2023	Sigma Planning Corp	12,865	$0.34M	0.0%	-31.5%	0.019%
11/2/2023	Quantum Private Wealth LLC	31,005	$0.81M	0.4%	+14.8%	0.045%
11/2/2023	Principal Financial Group Inc.	18,930	$0.49M	0.0%	+17.4%	0.028%
11/2/2023	Nisa Investment Advisors LLC	12,611	$0.33M	0.0%	-22.0%	0.018%
10/31/2023	Teacher Retirement System of Texas	16,486	$0.43M	0.0%	+4.7%	0.024%
10/27/2023	Allspring Global Investments Holdings LLC	8,542	$0.22M	0.0%	-27.5%	0.013%
10/27/2023	TD Asset Management Inc	210,746	$5.48M	0.0%	+110.4%	0.308%
10/26/2023	Inspire Investing LLC	11,602	$0.30M	0.0%	-10.2%	0.017%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	38,071	$0.99M	0.0%	+13.5%	0.056%
10/26/2023	Strs Ohio	24,100	$0.63M	0.0%	+99.2%	0.035%
10/24/2023	Weybosset Research & Management LLC	12,140	$0.32M	0.1%	+19.7%	0.018%
10/24/2023	Raymond James & Associates	27,545	$0.72M	0.0%	+104.3%	0.040%
10/24/2023	FSC Wealth Advisors LLC	15,000	$0.39M	0.4%	+50.0%	0.022%
10/11/2023	Canton Hathaway LLC	21,850	$0.57M	0.2%	+2.3%	0.032%

Data available starting January 2016

Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors; Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder; BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain; and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. It also offers BHV-1300, a product candidate in Phase 1 clinical trials to treat rheumatoid arthritis; BHV-1310 for the treatment of generalized myasthenia gravis and acute exacerbations or flares; BHV-1400 to treat IgA Nephropathy; and BHV-1600 for the treatment of dilated cardiomyopathy. In addition, the company develops BHV-1100, a product candidate in Phase 1a/1b clinical trials for multiple myeloma patients; BHV-1510, a preclinical product that targets carcinomas; and BHV-1500 for Hodgkin's lymphoma. It has license, development, and commercialization agreements with Yale University, AstraZeneca, University of Connecticut, Artizan Biosciences Inc., Reliant Glycosciences LLC, Katholieke Universiteit Leuven, BMS, and Highlightll Pharmaceutical Co. Ltd. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.

Today's Range

Now: $38.99

$37.75

$39.23

50 Day Range

MA: $51.11

$38.32

$59.74

52 Week Range

Now: $38.99

$12.35

$62.21

Volume

947,802 shs

Average Volume

1,254,132 shs

Market Capitalization

$3.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of Biohaven?: Biohaven's top insider shareholders include:
Gregory Bailey (Director)
John W Childs (Director)
Vlad Coric (CEO)
Matthew Buten (CFO)
George C Clark (CAO)
Irina Antonijevic (Director)
Learn More about top insider investors at Biohaven.
Who are the major institutional investors of Biohaven?: Biohaven's top institutional shareholders include:
Cypress Wealth Services LLC — 0.01%
Learn More about top institutional investors of Biohaven stock.
Which major investors are buying Biohaven stock?: In the last quarter, BHVN stock was bought by institutional investors including:
Cypress Wealth Services LLC
In the previous year, these company insiders have bought Biohaven stock:
Gregory Bailey (Director)
John W Childs (Director)
Vlad Coric (CEO)
Matthew Buten (CFO)
Learn More investors buying Biohaven stock.